Insider Trading History of Ng George K

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ng George K since 2015. This trader's CIK number is 1638744. At the time of last reporting, Ng George K was the Chief Executive Officer of Processa Pharmaceuticals, Inc.. (stock ticker symbol PCSA). Also see all insider trading activities at Processa Pharmaceuticals, Inc..

Note that in the past Ng George K also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Sorrento Therapeutics, Inc. (SRNE) by Ng George K

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 SRNE 90,000 $895,499 0 $0 0 $0
2017 SRNE 0 $0 40,000 $206,000 0 $0
2015 SRNE 12,341 $143,660 0 $0 0 $0

Yearly summary of insider trading at Processa Pharmaceuticals, Inc. (PCSA) by Ng George K

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 PCSA 87,200 $69,585 0 $0 0 $0
2024 PCSA 10,000 $27,000 0 $0 0 $0


Insider trading activities at 2 companies by Ng George K:

1. Sorrento Therapeutics, Inc. (SRNE)

2. Processa Pharmaceuticals, Inc. (PCSA)

Table 1. Insider trading of Sorrento Therapeutics, Inc. (SRNE) by Ng George K

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-02-28 SRNE Buy 90,000 9.95 895,499
2017-02-03 SRNE Sale 40,000 5.15 206,000
2015-08-21 SRNE Buy 888 13.46 11,951
2015-08-03 SRNE Buy 11,453 11.50 131,709

Table 2. Insider trading of Processa Pharmaceuticals, Inc. (PCSA) by Ng George K

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-01-27 PCSA Buy 87,200 .80 69,585
2024-01-30 PCSA Buy 10,000 2.70 27,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ng George K (Chief Executive Officer of Processa Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.